CARDIOVASCULAR SURGERY
Acute kidney injury (AKI) is reported in up to 30% of patients undergoing cardiac surgery and is a recognized independent predictor of morbidity and mortality. To date, no preventive strategies have been shown in clinical trials to reduce the occurrence of cardiac surgery-associated AKI.
How RenalGuard Prevents AKI in Cardiac Surgery
How RenalGuard Prevents AKI in Cardiac Surgery
RenalGuard demonstrated a 52% reduction in AKI vs. standard of care.
30% of patients undergoing cardiac surgery suffer from AKI Leading to higher morbidity and mortality.
- The KIDNEY study is a 220-patient (on-pump) randomized controlled study
- 110 patients in each arm (RenalGuard therapy vs. standard of care).
- Study conducted at a leading hospital in the UK.
- The number needed to treat (NNT) with the RenalGuard system to prevent AKI was 9 patients.
How RenalGuard Prevents AKI in Cardiac Surgery
Discover more about our extensive range of professional services. We constantly update this page, but if you still can’t find what you’re looking for, please feel free to get in touch with us – we will be more than happy to help.
Automated Fluid Management System
Before, During, and After Surgery
Mechanism of Action
Publications
We constantly update this page with the latest publications. If you still can’t find what you’re looking for, need more information about Tricvalve please feel free to get in touch with us – we will be more than happy to help.
© Copyright. All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.